Inactive Instrument

Exactus Inc Share Price OTC Bulletin Board

US30066P1021

Pharmaceuticals

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	5L 5L 4L 4L 7L 4.97Cr 7L 50.48L 19.74L 2.46Cr 19.49L 19.06L 8.5Cr	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	2.2Cr 1.94Cr 1.81Cr 1.66Cr 3.11Cr 211.19Cr 3.18Cr 21Cr 8.39Cr 104.5Cr 8.28Cr 8.1Cr 361.27Cr	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

18/11	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/24/06	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/24/01	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/23/05	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/23/30	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/23/02	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/23/10	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/23/15	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

18/11	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/24/16	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/24/16	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/23/05	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/23/02	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-0.87%	+4.04%	+58.60%	+163.92%	1,07900Cr
JOHNSON & JOHNSON	-0.45%	+3.87%	+57.95%	+52.18%	64TCr
ABBVIE INC.	+0.04%	+3.95%	+37.69%	+74.54%	47TCr
ROCHE HOLDING AG	-1.80%	+1.34%	+36.44%	+30.89%	35TCr
NOVARTIS AG	-1.43%	-0.02%	+34.33%	+40.16%	30TCr
ASTRAZENECA PLC	-2.23%	+0.77%	+11.41%	+14.52%	27TCr
NOVO NORDISK A/S	-1.52%	+4.01%	+2.51%	-38.99%	23TCr
AMGEN INC.	-1.39%	+5.90%	+27.70%	+64.00%	21TCr
GILEAD SCIENCES, INC.	-1.18%	+1.83%	+16.20%	+72.69%	16TCr
Average	-1.23%	+4.83%	+31.42%	+52.66%	41.22TCr
Weighted average by Cap.	-1.33%	+4.86%	+41.28%	+77.72%

	2022	2023
Net sales	16.27L 14.3L 13.34L 12.25L 22.93L 16Cr 23.49L 1.58Cr 61.88L 7.71Cr 61.08L 59.76L 27Cr	23.85L 20.96L 19.56L 17.95L 33.61L 23Cr 34.43L 2.32Cr 90.71L 11Cr 89.54L 87.6L 39Cr
Net income	-91.43L -80.34L -74.99L -68.82L -1.29Cr -88Cr -1.32Cr -8.89Cr -3.48Cr -43Cr -3.43Cr -3.36Cr -149.8Cr	-80.15L -70.43L -65.74L -60.33L -1.13Cr -77Cr -1.16Cr -7.8Cr -3.05Cr -38Cr -3.01Cr -2.94Cr -131.33Cr
Net Debt	1.79Cr 1.57Cr 1.46Cr 1.34Cr 2.52Cr 171.01Cr 2.58Cr 17Cr 6.79Cr 85Cr 6.7Cr 6.56Cr 292.54Cr	2.15Cr 1.89Cr 1.77Cr 1.62Cr 3.03Cr 206.22Cr 3.11Cr 21Cr 8.19Cr 102.04Cr 8.08Cr 7.91Cr 352.77Cr

Exactus Inc Share Price OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile